Clinical Studies and Case Reports

Title	Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
Author(s)	Aragona M, Onesti E, Tomassini V, Conte A, Gupta S, Gilio F, Pantano P, Pozzilli C, Inghilleri M.
Journal, Volume, Issue	Clin Neuropharmacol. 2008 Oct 23. [Epub ahead of print]
Major outcome(s)	Cannabis did not impair cognition
Indication	Multiple sclerosis	Abstract
Medication	Cannabis	OBJECTIVES
Route(s)	Sublingual
Dose(s)
Duration (days)	42
Participants	17 MS patients
Design	Controlled study
Type of publication	Medical journal
Address of author(s)	Chair of Philosophy of Psychopathology, "Sapienza" University; daggerDivision of Neurology, Neurological Centre of Latium; double daggerDepartment of Neurological Sciences, "Sapienza" University, Rome, Italy; and section signDepartment of Radiology, Westc
Full text

© Copyright 2009 Honolulu ASA. Honolulu ASA is the Honolulu, Hawaii chapter of Americans for Safe Access. We are required by federal law to tell you that any donations you make to Honolulu ASA may be used for political purposes, such as supporting or opposing candidates for federal office. Website designed and hosted by FRWebservices. For problems or questions regarding this Web site contact our Webmaster
Last updated: 11/26/09.